Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil for cognitive fatigue in MS
NCT00981084Phase 3Completed
- Sponsor
- University of Missouri-Kansas City
- Start
- Sep 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of armodafinil in multiple sclerosis (MS) (2 arms), sponsored by University of Missouri-Kansas City. Primary endpoints: Learning and Memory Measures, CPT - Test of Information Processing Speed and 2 more. Started Sep 2009; status: completed.
02
Drugs
armodafinil
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00981084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00981084.